The present paper describes two immunoconjugates consisting of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb), named Mint5, covalently linked to the type 1 ribosome-inactivating proteins (RIPs) ocymoidine (Ocy) and pyramidatine (Pyra) from Saponaria ocymoides and Vaccaria pyramidata respectively. Both antibody and toxins are shown to retain their respective biological properties upon chemical conjugation. The immunoconjugates exert specific inhibition of EGFR expressing target cell proliferation and protein synthesis in in vitro assays and also inhibit the growth of grafted human tumour cells in nude mice.

Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata / Di Massimo A.M.; Di Loreto M.; Pacilli A.; Raucci G.; D'Alatri L.; Mele A.; Bolognesi A.; Polito L.; Stirpe F.; De Santis R.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - STAMPA. - 75:6(1997), pp. 822-828. [10.1038/bjc.1997.147]

Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata

Pacilli A.;Bolognesi A.;Polito L.;Stirpe F.;
1997

Abstract

The present paper describes two immunoconjugates consisting of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb), named Mint5, covalently linked to the type 1 ribosome-inactivating proteins (RIPs) ocymoidine (Ocy) and pyramidatine (Pyra) from Saponaria ocymoides and Vaccaria pyramidata respectively. Both antibody and toxins are shown to retain their respective biological properties upon chemical conjugation. The immunoconjugates exert specific inhibition of EGFR expressing target cell proliferation and protein synthesis in in vitro assays and also inhibit the growth of grafted human tumour cells in nude mice.
1997
Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata / Di Massimo A.M.; Di Loreto M.; Pacilli A.; Raucci G.; D'Alatri L.; Mele A.; Bolognesi A.; Polito L.; Stirpe F.; De Santis R.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - STAMPA. - 75:6(1997), pp. 822-828. [10.1038/bjc.1997.147]
Di Massimo A.M.; Di Loreto M.; Pacilli A.; Raucci G.; D'Alatri L.; Mele A.; Bolognesi A.; Polito L.; Stirpe F.; De Santis R.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/959711
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 21
social impact